The aim of this presentation is to answer the question`Why are rabbits useful models for impotence research?'
Background
Reviewing the literature of the past three decades one ®nds clear evidence that studies in rabbit models have had a big impact on research of the physiology and pathophysiology of erectile function. 1 ± 4 Rabbits are of convenient size, strain speci®c, easily controllable and relatively inexpensive. The structure of the rabbit penis is rather similar to that of the human. There is a great similarity between human and rabbit neurological and non-neurological factors which modulate the tone of their corpus cavernosa. 5, 6 This has been shown in many in vitro organ bath studies using isolated corpus cavernosum. 7 Furthermore, it is possible to provoke pathophysiological situations in rabbits which are similar to that of humans and which have an impact on erectile function. For example, in the rabbit, a high cholesterol diet combined with de-endothelialisation of aorto-iliac arteries induces atherosclerotic plaques. Chronic ischemia, hypercholesteremia and hypertension induced alterations of the ®broelastic properties of the corporal tissue may contribute to the development of impotence. The underlying mechanism seems to be an increased output of constrictor eicosanoids and an impaired in¯uence of the NO pathway. 8, 9 As another example, alloxan-induced diabetic rabbits can be used to model diabetes induced erectile dysfunction. Alloxan diabetic animals have shown, for instance an increase in endothelin B receptor sites in corpus cavernosum smooth muscle cells, suggesting that ET1 has a role in the pathophysiology of diabetic erectile dysfunction. 10 Sullivan et al 11 have demonstrated an impaired formation of NO, Prostaglandin I 2 and of adenylyl cyclase activity, indicating that endothelial dysfunction is a major contributor to erectile dysfunction due to diabetes.
A further model with aging animals has demonstrated an up-regulation of endothelial NO synthase but at the same time a down-regulation of constitutive NO synthase which could parallel changes seen with erectile dysfunction. 12 Most in vivo studies have been done with anaesthetized animals. Anesthesia permits the study of neurological pathways by stimulating different types of nerves and also to allow measurement of several different parameters in parallel. The most frequently performed measurement is the continuous recording of the intracavernosal pressure using a transducer which is inserted into the corpus cavernosum. It is also possible to measure the penile volume by plethysmography. Anesthesia also allows the monitoring of hemodynamic parameters like blood pressure and heart rate. It has been shown that intracavernosal blood¯ow can be followed by laser Doppler¯owmetry. 13 Stief et al 14 evaluated the rabbit for the elucidation of the neurophysiology of erection, ejaculation and bladder function by stimulation of different peripheral nerves. Stimulation of the cavernous nerve induced penile erection, stimulation of the hypogastric nerve induced penile tumescence and contraction of the seminal vesicles. Stimulation of the sympathetic truncs induced contraction of the penis and of the seminal vesicles. In summary, rabbits are well characterized with respect to neurourological factors and in¯uence of pathophysiological situations on the erectile function. They are also well characterized with respect to pharmacostimulation with a lot of compounds in¯uencing penile function by different modes of action, eg prostaglandins, phosphodiesterase inhibitors, a-receptor blockers, NO donors, NO-synthase inhibitors and vasoactive intestinal peptide. There are many studies published with parallel investigations in vivo and in vitro with isolated corpus cavernosum in the organ bath.
However, in our experience, the anaesthetized rabbit model has some limitations. Often, compli-cated surgery is needed, anesthesia may in¯uence the experiments, and the number of compounds that can be tested in one animal is limited. Since the animals have to be killed after surgery the number of animals can be extensive when many compounds have to be compared for their in¯uence on erectile function. To limit the number of animals killed for the assessment of compounds which are candidates for drug development a new conscious rabbit model was developed. It is based on the work of Naguma et al 15 who showed, that different neuroleptics induce erections in conscious rabbits when given intramuscularly. Usually the penis of rabbits is not visible because it is covered by fur. If the animal gets an erection, it is easy to measure the length of the penis and the duration as a measure for the strength of the erection.
We could demonstrate that intravenous injection of the new and potent phosphodiesterase-5 (PDE5) inhibitor vardena®l 16 induced dose-dependent strong erections in conscious rabbits. We could also induce erections by oral administration of vardena®l in increasing doses. Low doses of 1 and 3 mgakg induced a measurable tumescence. The 10 mgakg dose induced a strong erection but there was no greater effect at 30 mgakg dose indicating that the maximal effect was achieved at the 10 mg dose. 17 We could con®rm also that the model was responsive to accepted agents for erectile dysfunction, eg oral sildena®l at 3, 10 and 25 mgakg induced erections as well.
Demonstration of the mode of action of a PDE5 inhibitor in this model
The injection of the NO donor sodium nitroprusside (SNP) (0.2 mgakg i.v.) alone induced a very small and short lasting erection (5 ± 10 min). Vardena®l (3 mgakg p.o.) alone only induced a relatively weak erection. But if SNP was injected 1 h after oral vardena®l, a very strong erection occurred with the 3 mgakg dose. This suggests that the effect of the PDE5 inhibitor is potentiated in the presence of NO and con®rms, that PDE5 inhibition ampli®es an enhanced production of cGMP induced by the NO donor SNP. Because these animals are not sexually stimulated, SNP is used to mimic sexual stimulation. It can be expected the effect of vardena®l would also be ampli®ed during sexual stimulation when NO production is enhanced.
We could show that a low dose of vardena®l (0.3 mgakg p.o.) had no effect by itself, but in combination with SNP, the effect was clearly higher than the effect of SNP alone.
This indicates that under stimulated conditions, ie in the presence of NO, effective doses of vardena®l can be about 10-fold lower to achieve the same effect compared to unstimulated conditions. The effective dose (0.3 mgakg p.o.) of vardena®l in this conscious rabbit model is within the range of doses which are being tested in clinical trials suggesting that the model is a valuable tool for the assessment of the in vivo ef®cacy of PDE5 inhibitors.
If an inhibitor of NO synthesis (L-NAME) was given 10 min before vardena®l administration, the effect of vardena®l (1 mgakg i.v.) was nearly abolished. Under these conditions, the PDE5 inhibitor is much less effective. The impaired NO synthesis leads to an decreased cGMP turnover.
Summary
The anesthetized rabbit model is useful and has many advantages: ability to perform neurophysiological studies; more administration routes, including intracavernous injection; haemodynamic measurements in parallel to measurements of intracavernous pressure or penile volume; and direct measurement of intracavernosal pressure and blood¯ow. This model has been evaluated with many different types of drugs.
The conscious rabbit model is a simple and valid model for the assessment of compounds with potential for treatment of ED. It offers several methodological advantages as a screening model for compounds with erection stimulating properties. It was clearly successful in demonstrating the ef®cacy and the mechanism of the new potent and selective PDE5 inhibitor vardena®l. The model was also effective in demonstrating erection-generating properties through other mechanisms, eg PDE3 inhibitors and a-receptor blockers.
In conclusion, both anaesthetized rabbit model and the newly developed conscious-rabbit models are well-suited for studies in impotence research. 
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